AKT1 and hepatocellular carcinoma: Past studies have shown that the PI3K-Akt signaling pathway was involved in the invasion and metastasis of a variety of cancers, including hepatocellular carcinoma (73), gastric cancer (74, 75), lung adenocarcinoma (76), colorectal cancer (77), and renal cell carcinoma (78).